Dr. Paul Wotton, CEO of Obsidian Therapeutics, discusses Obsidian’s platform, cytoDRiVE™, that regulates protein levels in cell and gene therapies, creating an “operating system” for living drugs. This means that now, and for the first time, physicians will be able to control genetically-engineered cells’ biologic activity to increase efficacy and reduce toxicity, using easily accessed generics […]

A Massachusetts patient with COVID-19 and pneumonia responded positively to a laser therapy meant to promote healing, according to a case study published in the American Journal of Case Reports. The article details a COVID-19 case involving a 57-year-old man admitted to the intensive care unit for respiratory distress. The man had daily, 28-minute sessions of photobiomodulation therapy […]

A proprietary formulation of vasoactive intestinal peptide (VIP) called RLF-100 (a.k.a. aviptadil) might have helped critically ill COVID-19 patients, although initial results touted by the product’s developers in a press release remain to be confirmed in well-designed trials. If the product does succeed, it would complete a 50-year effort to bring VIP into the clinic as a […]